Scientists track side effects of senior flu shot
NCT ID NCT07282795
Summary
This study aims to monitor the safety of a high-dose flu vaccine (Efluelda®) in adults aged 65 and older in South Korea. Researchers will track any side effects or reactions that occur in about 670 participants for approximately one month after they receive their routine flu shot. The goal is to gather real-world safety information on this already-approved vaccine as it's used in standard healthcare settings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.